Wills Hughes-Wilson
Corporate Officer/Principal bei MEREO BIOPHARMA GROUP PLC
Vermögen: 860 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Wills Hughes-Wilson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 32 | |
| Public Company | Pharmaceuticals: Major | 30 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Wills Hughes-Wilson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Investment Committee Member Chief Executive Officer Director/Board Member Director/Board Member Private Equity Investor Director/Board Member | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member President General Counsel Corporate Officer/Principal | |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Part of Mereo BioPharma Group Plc, Mereo Biopharma 3 Ltd. develops bio pharm products. The company is based in London, UK. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 2 Ltd. is a British company that provides research and experimental development for biotechnology. The company is based in London, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mereo BioPharma Group Plc, Mereo BioPharma 4 Ltd. is a British biotechnology company founded in 2017 that provides research and development services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BTG | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Chairman | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| University of Mumbai | College/University | Graduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| The University of Sheffield | College/University | Undergraduate Degree Undergraduate Degree | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| AVROBIO, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Lund | College/University | Graduate Degree Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer | |
| ABLYNX | Biotechnology | Chairman Chairman | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 18 |
| Schweden | 14 |
| Vereinigtes Königreich | 12 |
| Dänemark | 4 |
| Schweiz | 3 |
Sektoral
| Health Technology | 35 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Finance | 3 |
Operativ
| Director/Board Member | 382 |
| Corporate Officer/Principal | 139 |
| Independent Dir/Board Member | 118 |
| Chairman | 89 |
| Chief Executive Officer | 62 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Paul Blackburn | 46 |
| Sven Håkan Björklund | 46 |
| Frank Armstrong | 41 |
| Bo Jesper Hansen | 34 |
| Deepa Pakianathan | 32 |
| Michael Wyzga | 31 |
| Anders Olof Adolf Ekblom | 27 |
| John P. Richard | 24 |
| Peter John Fellner | 21 |
| Jeff Jonas | 21 |
| Denise Scots-Knight | 20 |
| Peter Bains | 19 |
| Guido Oelkers | 19 |
| Alan Henry Raffensperger | 17 |
- Börse
- Insiders
- Wills Hughes-Wilson
- Unternehmensverbindungen
